Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Talis Biomedical Corp as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −2 vs. Q4 2021
- Shares held
- 16.7M
- −755.5K (−4.3%) vs. Q4 2021
- Total value
- $23.6M
- −$46.5M (−66.3%) vs. Q4 2021
- New holders
- 6
- 10 more added
- Sold out
- 8
- 23 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLIS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $26 |
| Q3 2024 | 2 | $460.4K |
| Q2 2024 | 18 | $6.84M |
| Q1 2024 | 18 | $6.93M |
| Q4 2023 | 18 | $5.93M |
| Q3 2023 | 19 | $4.27M |
| Q2 2023 | 22 | $5.27M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 27 | $5.60M |
| Q3 2022 | 29 | $8.59M |
| Q2 2022 | 35 | $12.1M |
| Q1 2022 | 45 | $23.6M |
| Q4 2021 | 47 | $70.2M |
| Q3 2021 | 38 | $119.2M |
| Q2 2021 | 43 | $184.0M |
| Q1 2021 | 45 | $269.0M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Talis Biomedical Corp; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 117 | $0 | 0.00% | +117 | New |
| Royal Bank of Canada | 1,158 | $1.00K | 0.00% | −1,780−60.6% | Reduced |
| Simplex Trading, LLC | 1,064 | $1.00K | 0.00% | −167−13.6% | Reduced |
| Advisor Group Holdings, Inc. | 2,000 | $2.00K | 0.00% | −150−7.0% | Reduced |
| Legal & General Group Plc | 1,074 | $2.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,077 | $2.00K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,803 | $3.00K | 0.00% | +1,803 | New |
| Amalgamated Financial Corp. | 1,803 | $3.00K | 0.00% | +1,803 | New |
| Wells Fargo & Company | 3,072 | $4.00K | 0.00% | −4,951−61.7% | Reduced |
| UBS Group AG | 2,745 | $4.00K | 0.00% | −4,734−63.3% | Reduced |
| Citigroup Inc | 3,794 | $5.00K | 0.00% | +115+3.1% | Added |
| Barclays PLC | 3,441 | $5.00K | 0.00% | +3,441 | New |
| FMR LLC | 3,585 | $5.00K | 0.00% | +3,585 | New |
| California State Teachers Retirement System | 6,552 | $9.00K | 0.00% | −1,223−15.7% | Reduced |
| New York State Common Retirement Fund | 6,075 | $9.00K | 0.00% | +31+0.5% | Added |
| JPMorgan Chase & Co | 6,948 | $10.0K | 0.00% | −111,755−94.1% | Reduced |
| American International Group, Inc. | 7,355 | $10.0K | 0.00% | −322−4.2% | Reduced |
| Deutsche Bank AG | 7,839 | $11.0K | 0.00% | −942−10.7% | Reduced |
| Tudor Investment Corp Et Al | 10,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,805 | $15.0K | 0.00% | −1,412−11.6% | Reduced |
| Rhumbline Advisers | 11,403 | $16.0K | 0.00% | −1,178−9.4% | Reduced |
| Mercer Global Advisors Inc | 11,380 | $16.0K | 0.00% | +345+3.1% | Added |
| Tower Research Capital LLC (TRC) | 15,767 | $22.0K | 0.00% | +10,175+182.0% | Added |
| Renaissance Technologies LLC | 16,598 | $23.0K | 0.00% | +16,598 | New |
| Golden State Equity Partners | 22,133 | $31.0K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 23,800 | $34.0K | 0.00% | −1,100−4.4% | Reduced |
| Charles Schwab Investment Management Inc | 31,324 | $45.0K | 0.00% | −5,390−14.7% | Reduced |
| Bank of America Corp | 36,958 | $52.0K | 0.00% | −11,065−23.0% | Reduced |
| Qube Research & Technologies Ltd | 47,467 | $67.0K | 0.00% | −11,694−19.8% | Reduced |
| Bank of New York Mellon Corp | 52,462 | $74.0K | 0.00% | −2,084−3.8% | Reduced |
| Bridgeway Capital Management, LLC | 54,000 | $76.0K | 0.00% | +21,500+66.2% | Added |
| Nuveen Asset Management, LLC | 53,809 | $82.0K | 0.00% | +3,522+7.0% | Added |
| Two Sigma Investments, LP | 73,828 | $104.0K | 0.00% | −4,800−6.1% | Reduced |
| Northern Trust Corp | 123,761 | $175.0K | 0.00% | −3,867−3.0% | Reduced |
| Parametric Portfolio Associates LLC | 138,917 | $196.0K | 0.00% | +62,979+82.9% | Added |
| Morgan Stanley | 150,297 | $212.0K | 0.00% | −26,037−14.8% | Reduced |
| State Street Corp | 251,610 | $355.0K | 0.00% | −14,697−5.5% | Reduced |
| Prelude Capital Management, LLC | 256,395 | $362.0K | 0.02% | +68,126+36.2% | Added |
| Geode Capital Management, LLC | 264,904 | $373.0K | 0.00% | −16,661−5.9% | Reduced |
| Vanguard Group Inc | 612,432 | $864.0K | 0.00% | −112,701−15.5% | Reduced |
| BlackRock Inc. | 820,993 | $1.16M | 0.00% | +4,962+0.6% | Added |
| Greenlight Capital Inc | 2,235,783 | $3.15M | 0.20% | +666,483+42.5% | Added |
| ArrowMark Colorado Holdings LLC | 3,735,237 | $5.27M | 0.05% | −1,180,002−24.0% | Reduced |
| Baker Bros. Advisors LP | 7,624,835 | $10.8M | 0.06% | 00.0% | Unchanged |
| PDT Partners, LLC | 0 | $0 | 0.00% | −34,890−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −34,707−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −13,670−100.0% | Sold out |
| Personal Cfo Solutions, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −7,946−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −828−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −41−100.0% | Sold out |